Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40119-016-0059-1 http://scihub22266oqcxt.onion/10.1007/s40119-016-0059-1 C4906086!4906086!27016085     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cardiol+Ther 2016 ; 5 (1): 75-82 Nephropedia Template TP {{tp|p=27016085|t=2016. Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases |pdf=|usr=}}{{27016085}} gab.com Text Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases JO: Cardiol Ther http://www.kidney.de/pget.php?&tw=1&pmid=27016085 #FOAvip Abstract : Cardiovascular diseases are the leading cause of death in the world. Coronary artery diseases, atrial fibrillation or hypertensive heart disease, are among the most important cardiovascular disorders. Hypertension represents a significant risk factor for cardiovascular mortality; thus, control of high blood pressure has become a priority to prevent major complications. Although the choice of drugs for treating hypertension remains controversial, extensive clinical evidences point to calcium channel blockers as first-line agents. Diltiazem, a non-dihydropyridine calcium channel blocker, is an effective and safe antihypertensive drug, alone or in combination with other agents. Diltiazem lowers myocardial oxygen demand through a reduction in heart rate, blood pressure, and cardiac contractility, representing also a good alternative for the treatment of stable chronic angina. Furthermore, diltiazem reduces conduction in atrioventricular node, which is also useful for heart rate control in patients with atrial fibrillation. In this review, clinical experts highlight studies on diltiazem effectiveness and safety for the treatment of several cardiovascular diseases and make evidence-based recommendations regarding the management of diltiazem in the clinical practice. Funding: Lacer Spain. Twit Text FOAVip Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases ????Cardiol Ther http://www.kidney.de/pget.php?&tw=1&pmid=27016085 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27016085 #FOAvip English Wikipedia <ref>{{Cite pmid|27016085}}</ref> Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases #MMPMID27016085 Rodríguez Padial L; Barón-Esquivias G; Hernández Madrid A; Marzal Martín D; Pallarés-Carratalá V; de la Sierra A Cardiol Ther 2016[Jun]; 5 (1): 75-82 PMID27016085show ga Abstract : Cardiovascular diseases are the leading cause of death in the world. Coronary artery diseases, atrial fibrillation or hypertensive heart disease, are among the most important cardiovascular disorders. Hypertension represents a significant risk factor for cardiovascular mortality; thus, control of high blood pressure has become a priority to prevent major complications. Although the choice of drugs for treating hypertension remains controversial, extensive clinical evidences point to calcium channel blockers as first-line agents. Diltiazem, a non-dihydropyridine calcium channel blocker, is an effective and safe antihypertensive drug, alone or in combination with other agents. Diltiazem lowers myocardial oxygen demand through a reduction in heart rate, blood pressure, and cardiac contractility, representing also a good alternative for the treatment of stable chronic angina. Furthermore, diltiazem reduces conduction in atrioventricular node, which is also useful for heart rate control in patients with atrial fibrillation. In this review, clinical experts highlight studies on diltiazem effectiveness and safety for the treatment of several cardiovascular diseases and make evidence-based recommendations regarding the management of diltiazem in the clinical practice. Funding: Lacer Spain. äClinical Experience with Diltiazem in the Treatment of Cardiovascular (epmc).pdf DeepDyve Pubget Overpricing